Amputations News and Research

RSS

Alligator blood may provide a source of powerful new antibiotics

Despite their reputation for deadly attacks on humans and pets, alligators are wiggling their way toward a new role as potential lifesavers in medicine, biochemists in Louisiana reported today at the 235th national meeting of the American Chemical Society.

7 Apr 2008

Alligator blood extract promises to help fight superbugs

Biochemists from Louisiana in the U.S. say blood from alligators could help fight deadly 'superbugs' and other infections.

7 Apr 2008

New genetic clues to diabetes

An international team that included scientists from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today reported it has identified six more genetic variants involved in type 2 diabetes, boosting to 16 the total number of genetic risk factors associated with increased risk of the disease.

1 Apr 2008

New genetic clues to diabetes

31 Mar 2008

Type 2 diabetes genes linked with prostate cancer

Scientists have identified six new genes which play a role in the development of type 2 diabetes, and among the group is the second gene known to also play a role in prostate cancer.

31 Mar 2008

MGH initiates trial to reverse type 1 diabetes

Scientists at the Massachusetts General Hospital (MGH) have initiated a phase 1 clinical trial to reverse type 1 diabetes.

14 Mar 2008

Racial and ethnic differences among patients with extremity soft-tissue sarcomas

A new study reveals significant racial and ethnic differences in the treatment and survival of patients with soft-tissue sarcomas, a rare but dangerous cancer that begins in muscle, fat, blood vessels or other supporting tissue of the body.

23 Jan 2008

New York City mortality rate at all-time low in 2006

The death rate in New York City reached an all-time low in 2006, the Health Department reported today, as the number of deaths fell to 55,391 - down from 57,068 in 2005 and 60,218 in 2001.

10 Jan 2008

Depressed, older adults with diabetes live longer when they are treated for depression

The depression study, which followed primary care patients in the New York City, Philadelphia and Pittsburgh areas for five years, also showed that treating depression reduced mortality more for those who had diabetes than for those who did not.

27 Nov 2007

Lack of health insurance may stop some diabetics from seeking critical treatment

With more than 80,000 lower-limb amputations reported annually among people with diabetes in the United States, there's a possibility many amputations, especially among African-Americans, could have been prevented if patients had health insurance.

20 Nov 2007

EDMA calls for empowering people with diabetes

Type 2 diabetes and its complications are frequently diagnosed too late and the complications are often detected only at the time of diagnosis, concludes the European Parliament in its 2006 Written Declaration on Diabetes.

14 Nov 2007

More than six out of ten people with diabetes are walking around in the wrong-sized shoes

More than six out of ten people with diabetes are walking around in the wrong-sized shoes, exposing themselves to serious foot problems that could lead to amputation, according to research in the November issue of IJCP, the International Journal of Clinical Practice.

14 Nov 2007

Fenofibrate intervention and event lowering in diabetes

Fenofibrate is the first and only widely available lipid modifying agent to demonstrate significant protection to the eye of patients with type 2 diabetes, reducing the need for laser therapy in a wide spectrum of patients which should decrease the risk of progressive loss of vision.

6 Nov 2007

Sanofi Pasteur receives FDA approval of Menactra meningococcal vaccine for children

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.

22 Oct 2007

Many patients with diabetes say burden of care rivals complications of disease

Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.

27 Sep 2007

AGE-rich foods causes dysfunction linked to heart disease

A study in this month's Diabetes Care finds that ingesting food or drink rich in advanced glycation end products (AGEs) causes immediate, short-lived but significant endothelial dysfunction, shedding light on the mechanism by which dietary AGE content can be linked to cardiovascular disease.

27 Sep 2007

Study looks at salsalate for type 2 diabetes

The University of Illinois at Chicago is one of 16 sites in the United States taking part in the first large-scale study to test a promising approach to lowering blood glucose levels in adults with type 2 diabetes.

24 Aug 2007

Lower-limb injuries common place in U.S. soldiers in Iraq

A study released in advance of the American Podiatric Medical Association's (APMA) 95th Annual Meeting in Philadelphia reveals nearly 68 percent of all U.S. soldiers wounded in the Iraq and Afghanistan conflicts are a result of extremity injuries and nearly 22 percent of those injuries involve the foot and/or ankle.

16 Aug 2007

Improving the quality of primary care could prevent 4 million hospitalizations each year

More than 4 million hospitalizations potentially could be prevented each year by improving the quality of primary care, enhancing patients' access to effective treatments, and getting more Americans to adopt healthy behaviors, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

13 Aug 2007

Avandia too risky says expert

One of the members of the advisory panel set up to discuss the future of the diabetes pill Avandia says it should be removed from the market because it is too risky and offers no advantage over other alternatives.

30 Jul 2007